Tick-Borne Encephalitis (Inactivated) Vaccine Dosage

Medically reviewed by Drugs.com. Last updated on Nov 13, 2022.

Usual Adult Dose for Tick-Borne Encephalitis Vaccination

0.5 mL IM each dose

Primary Vaccination Schedule:

First dose: Day 0
Second dose: 14 days to 3 months after the first dose
Third dose: 5 to 12 months after the second dose

Comments:

The primary immunization series should be completed at least 1 week before potential exposure to tick-borne encephalitis virus (TBEV).
A booster dose (fourth dose) may be administered at least 3 years after completion of the primary immunization series if continued exposure or re-exposure to TBEV is expected.

Use: For active immunization to prevent tick-borne encephalitis

Usual Pediatric Dose for Tick-Borne Encephalitis Vaccination

1 through 15 years: 0.25 mL IM each dose
16 years or older: 0.5 mL IM each dose

Primary Vaccination Schedule:

First dose: Day 0
Second dose:
Aged 1 through 15 years: 1 to 3 months after the first dose
Aged 16 years or older: 14 days to 3 months after the first dose
Third dose: 5 to 12 months after the second dose

Comments:

The primary immunization series should be completed at least 1 week before potential exposure to TBEV.
A booster dose (fourth dose) may be administered at least 3 years after completion of the primary immunization series if continued exposure or re-exposure to TBEV is expected.

Use: For active immunization to prevent tick-borne encephalitis

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:
Severe allergic reaction (e.g., anaphylaxis) to the active component or any of the ingredients

Safety and efficacy have not been established in patients younger than 1 year.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

For IM use only
Administer by IM injection.

Storage requirements:

Store refrigerated at 2C to 8C (36F to 46F).
Keep syringe in outer carton to protect from light.
Do not freeze; discard if the vaccine has been frozen.

Reconstitution/preparation techniques:

Before administration, the vaccine should be brought to room temperature.
Before administration, the vaccine suspension should be thoroughly mixed by shaking well; after shaking, the vaccine should be a homogenous off-white, opalescent suspension.
The manufacturer product information should be consulted.

Patient advice:

It is important to complete the approved 3-dose primary immunization series before potential exposure to TBEV.
Report any side effects to a health care professional.